Published in Gene Therapy Weekly, November 17th, 1997
Research has confirmed that tumor cells escape the host's immune surveillance system because they do not provide the essential signals for the activation of the host immune system. Vaccinating patients with tumor cells, modified so that the immune system recognizes them, is one method of bypassing this problem. Several vaccines have undergone scrutiny.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.